Oct 14, 2026 06:04AM
Sep 16, 2026 01:24AM
Aug 24, 2026 05:16AM
Aug 14, 2026 07:14AM
Jul 29, 2026 09:26AM
Jun 1, 2026 04:41AM
May 11, 2026 04:50AM Alvotech completes FDA inspection at Iceland facility
Mar 31, 2026 03:31AM
Mar 24, 2026 09:33AM
Mar 23, 2026 02:43PM
Feb 11, 2026 11:00AM
Feb 5, 2026 05:48AM
Feb 2, 2026 04:42AM
Jan 29, 2026 04:50AM Alvotech settles global patent disputes for Eylea biosimilar
Jan 6, 2026 07:16AM
Dec 31, 2025 04:30PM
Dec 22, 2025 05:39AM
Dec 19, 2025 05:13AM
Dec 17, 2025 08:39AM
Nov 24, 2025 05:31AM
Nov 20, 2025 04:00AM Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz
Nov 12, 2025 06:02PM
Nov 10, 2025 04:02AM
Nov 6, 2025 09:00AM
Nov 4, 2025 04:49AM
Nov 3, 2025 03:52AM
Oct 14, 2025 03:26AM
Oct 6, 2025 04:55AM EMA accepts biosimilar application for Alvotech's omalizumab drug
Sep 23, 2025 03:58AM
Sep 22, 2025 06:18AM
Sep 22, 2025 05:11AM
Sep 19, 2025 07:46AM
Aug 20, 2025 06:06AM
Aug 13, 2025 04:31PM
Aug 13, 2025 04:31PM Alvotech (ALVO) Reports 1H EPS of $0.50
Jul 10, 2025 06:08AM
Jun 25, 2025 04:15AM
Jun 23, 2025 05:14AM
Jun 11, 2025 04:19PM
Jun 5, 2025 08:58AM
May 21, 2025 07:22AM
May 7, 2025 04:58PM Alvotech (ALVO) Tops Q1 EPS by 32c
May 5, 2025 07:03AM
Mar 20, 2025 11:43AM
Mar 18, 2025 08:32AM
Feb 21, 2025 06:26AM
Feb 14, 2025 11:10AM
Feb 12, 2025 03:40AM
Jan 27, 2025 06:02AM Alvotech (ALVO) and Teva (TEVA) Announce Filing Acceptance of U.S. Biologics License Applications for AVT05
Nov 4, 2024 07:03AM

479,075 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All